AFP
AMAG

Ausdal Financial Partners’s AMAG Pharmaceuticals AMAG Stock Holding History

Ausdal Financial Partners’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,376
Closed -$42K – 1133
2015
Q4 		$42K Buy
+1,376
New +$44.5K 0.02% 515

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return

Ausdal Financial Partners's AMAG Position: Q1 2016 in Review

Ausdal Financial Partners sold out of AMAG Pharmaceuticals (AMAG) in Q1 2016, closing a stake of 1,376 shares — an estimated $42K sold.

Ausdal Financial Partners first reported a position in AMAG in Q4 2015 and held it in 1 quarter. The position peaked at $42K in Q4 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2016.

  • Ausdal Financial Partners reported no remaining AMAG Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Ausdal Financial Partners sold 1,376 AMAG Pharmaceuticals shares in Q1 2016, an estimated $42K.
  • Ausdal Financial Partners first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 1 quarter.
  • Ausdal Financial Partners's AMAG Pharmaceuticals position peaked at $42K in Q4 2015.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2016.

Based on Ausdal Financial Partners's 13F filing for Q1 2016, filed 5 May 2016.